Question 1

Does Sculptor Capital own IBRX stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Sculptor Capital holds 79,200 shares of IBRX (Immunitybio), worth $693,396.

Question 2

How many shares of IBRX does Sculptor Capital own?

Accepted Answer

As of its Q2 2026 13F, Sculptor Capital holds 79,200 shares of IBRX (Immunitybio).

Question 3

What is Sculptor Capital's IBRX position worth?

Accepted Answer

As of its Q2 2026 13F, Sculptor Capital's IBRX position is worth $693,396.

Question 4

Is Sculptor Capital buying or selling IBRX?

Accepted Answer

In Q2 2026, Sculptor Capital reduced its IBRX position by 10,000 shares (-11.2%).

Question 5

When did Sculptor Capital first buy IBRX?

Accepted Answer

Sculptor Capital already held IBRX in its Q1 2021 13F, the earliest on record, and has listed it in 19 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	79,200	-11.2%	$693,396	0.0%	$8.76	0
2026-Q1	Decreased	89,200	-85.6%	$684,164	0.0%	$7.67	0
2025-Q4	Unchanged	619,000	0.0%	$1.2M	0.0%	$1.98	0
2025-Q3	Increased	619,000	+100.6%	$1.5M	0.0%	$2.46	41
2025-Q2	New	308,600	—	$814,704	0.0%	$2.64	34
2025-Q1	Exited	0	-100.0%	$0	0.0%	$3.01	0
2024-Q4	Increased	270,800	+24.3%	$693,248	0.0%	$2.56	30
2024-Q3	Increased	217,800	+77.8%	$810,216	0.0%	$3.72	38